EIR Ventures
EIR Ventures is a life science venture capital firm supported by InnovFin Equity and Saminvest AB. They focus on financing the development of innovative medicine and have a portfolio of companies across various therapeutic areas.
Investment Stages
Series A
Series B
Markets
Life Science
Portfolio Companies
Moleculent, RAPP, GutCRINE, Hoba Therapeutics, Scenic Biotech, SACRA Therapeutics, ArgusEye, Pretzel, IO Biotech, Galecto Biotech, Purpose Pharma, Henlez, Attgeno, Cinclus Pharma, Strike Pharma, Dania Tx, ISD-Immunotech, one-carbon Therapeutics, Synklino, Sortina Pharma
Related VC firms in Sweden
Antler
AI/Machine Learning, Consumer, EdTech, FinTech, Food and AgriTech, HealthTech, Logistics and Manufacturing, Media, Mobility, PropTech, E-Commerce, SaaS
Atomico
Digital Work, Enterprise AI & Automation, Internet Infrastructure & Security, Future Finance, Mobility, Industrial Automation, Frontier Tech, Planet Positive, Engaged Consumer, Future of Food, Digital Life & Play, Improving Health, Empowered Individuals
Base Partners
Technology, Enterprise, Consumer, Climate, Crypto, Financial, Services, Commerce, Foodtech, Logistics, Education, Media, Gaming, Healthcare, Dev Tools, Social